Records containing: Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-07-01Phase 1 Dose-Escalation Study of LY2157299 Monotherapy in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-06-24A Phase I Dose Escalation Trial of BIBW 2992 Administration for 20, 13 or 6 Days in Combination With Docetaxel Every 21 Days
-
CLINICAL_TRIALS study record update · 2014-06-24A Phase I Open Label Dose Escalation Study of Once-daily Oral Treatment With BIBW 2992 for 14 Days in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-06-24A Phase I Open-label Dose Escalation Study of Single Oral Daily Doses of BIBW 2992 for Three Days After Administration of Docetaxel, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-06-24A Phase I Open Label Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-06-24A Phase I Open Label Dose Escalation Study of Once-daily Oral Treatment With BIBW 2992 for 28 Days in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2014-06-23Phase I Study With Sorafenib in Combination With Carboplatin and Paclitaxel to Evaluate the Safety and Pharmacokinetics of This Combination in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-05-08A Phase II, Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of AZD8931 In Combination With Anastrozole, Compared to Anastrozole Alone, in Post Menopausal Women With Hormone Receptor Positive, Endocrine Therapy Naive, Locally Advanced or Metastatic Breast Cancer (MINT).
-
CLINICAL_TRIALS study record update · 2014-05-07EPREX (Epoetin Alfa) Versus ARANESP (Darbepoetin Alfa): Looking at Outcome of Anemia Treatment and Comparing Cost-effectiveness (EVALUATE).
-
CLINICAL_TRIALS study record update · 2014-04-28Blood Management Observation in Oncology Surgical Treatment (BOOST)
-
CLINICAL_TRIALS study record update · 2014-04-17Phase I Open Label Trial to Assess Safety of BIBW 2992 With Vinorelbine in Solid Tumors Known to Overexpress HER2 and/or EGFR
-
CLINICAL_TRIALS study record update · 2014-03-31A Phase I Study of PT-523 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-03-06A Phase I Trial of STA-4783 in Patients Receiving Paclitaxel for Treatment of Solid Tumors
-
CLINICAL_TRIALS study record update · 2014-03-04Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines
-
CLINICAL_TRIALS study record update · 2014-02-17PET-CT in Diagnosis of Pancreatic Cystic Neoplasms
-
CLINICAL_TRIALS study record update · 2014-02-13A Phase 1 Trial of the Combination of Perifosine and Docetaxel With or Without Prednisone
-
CLINICAL_TRIALS study record update · 2014-02-13Phase 1 Trial of the Combination of Perifosine and Gemcitabine
-
CLINICAL_TRIALS study record update · 2014-02-13A Phase 1 Trial of the Combination of Perifosine and Paclitaxel Given Either Weekly or Every 3 Weeks
-
CLINICAL_TRIALS study record update · 2014-02-07Outlook: An Intervention to Improve Quality of Life in Serious Illness
-
CLINICAL_TRIALS study record update · 2014-02-07Enhanced Self-Efficacy Training For Informal Cancer Caregivers
-
CLINICAL_TRIALS study record update · 2014-02-06Evaluation of the Cost and Effectiveness in the First-line Treatment of Advanced Renal Cell Cancer With Sunitinib Compared to Interferon-alfa in Finland.
-
CLINICAL_TRIALS study record update · 2014-02-03Phase I Dose-escalation, Pharmacokinetic and Pharmacodynamic Study of Debio 0932, a Novel Hsp90-inhibitor, Administered Orally, in Patients With Advanced Solid Tumours or Lymphoma
-
CLINICAL_TRIALS study record update · 2014-01-29A Randomized, Open-label, Comparative Study to Estimate the Effect of Darbepoetin Alfa on Hospital Days, Economic Outcomes, and Health-related Quality of Life in Subjects With Nonmyeloid Malignancies and Anemia of Cancer
-
CLINICAL_TRIALS study record update · 2014-01-23Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Solid Tumor
-
CLINICAL_TRIALS study record update · 2014-01-17An Open-Label Treatment Protocol for the Use of Voraxaze as Adjunctive Treatment for Patients Experiencing or at Risk of Methotrexate Toxicity